Accessibility and Benefit of FUS treatment for inoperable Lung Cancer Patients, a retrospective Analysis

Project Name: Accessibility and Benefit of FUS treatment for inoperable Lung Cancer Patients, a retrospective Analysis
Status: Complete
Sponsor Organization: Focused Ultrasound Foundation
Funded Date: Dec 14, 2017
Funding Program: Research Award
Funding Period: Dec 14, 2017 - Feb 13, 2019
Amount Awarded: $62,000.00

Abstract

Lung cancer (lc) is the mortality leading tumor entity in male and female. Curative treatment requires surgical resection, but 70% of patients are inoperable in moment of diagnosis. Hifu as a noninvasive treatment is not applicable in ventilated lung. By using one lung flooding (olf) acoustic access to central tumors can be generated without damaging the lung. Our work showed the usability of sonographic and mr guidance as well as therapeutic effects of fus on lung cancer. For preserving quality of life, local tumor control by a minimal invasive, repetitive treatment modality like fus would be beneficial. The clinical prospective of fus in lung remain unclear, which depends on the accessibility of inoperable lc patients to olf and fus. Therefore patient files will be analyzed regarding their accessibility to olf and fus. In addition tumor location and volume will be classified to derive technical requirements of fus systems

Contact Roles

Reports

No reports found.

The Focused Ultrasound Foundation Newsletter

Our newsletter delivers updates for clinicians, researchers and patients. Sign up and stay on top of the rapid advancements of this innovative medical technology.

Sign Up  Read the Latest Issue

Read The Tumor  by John Grisham

From John Grisham, comes a story where today’s medical fiction could become tomorrow’s lifesaving reality.

Download a Free eBook or Audiobook

Contact Details

Call Us
434.220.4993
Find Us
Focused Ultrasound Foundation
1230 Cedars Court, Suite 206 Charlottesville, VA 22903
Email